Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma.

Daniel Q HuangJoseph K HoangRubayet Kamal Pei-Chien Tsai Hidenori Toyoda Ming-Lun YehSatoshi YasudaJennifer LeongMayumi MaedaChung-Feng HuangDae Won JunMasatoshi IshigamiYasuhito Tanaka Haruki Uojima Eiichi OgawaHiroshi AbeYao-Chun HsuCheng-Hao TsengManaf AlsudaneyJu Dong YangYoko YoshimaruTakanori SuzukiJoanne K LiuCharles LandisChia-Yen Dai Jee-Fu Huang Wan-Long ChuangMyron SchwartzYock Young Dan Carlos O Esquivel Andrew Bonham Ming-Lung Yu Mindie H Nguyen

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)

Antiviral therapy is associated with long-term survival in people with HBV- or HCV-related HCC who undergo curative resection but is severely underutilized.

Keyphrases

hepatitis b virus
hepatitis c virus
liver failure
human immunodeficiency virus
prognostic factors
stem cells
metabolic syndrome
mesenchymal stem cells
cell therapy
hiv infected
smoking cessation